Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc. (STTK) from its SEC filings: 2025 revenue $1.0 million (-82% vs the year before), net margin -4881%, free cash flow -$40.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $1.0 million |
| Revenue growth | -82% |
| Net income | -$48.8 million |
| Net margin | -4880.9% |
| Free cash flow | -$40.0 million |
| Diluted EPS | $-0.70 |
| Cash | $63.3 million |
| Share count, 1 year | +110% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.